Physician

Jami Lynn Reaves, DO

According to 2025 Medicare claims, Jami Reaves, DO (NPI: 1679783567) practices dermatology in the Kingsport-Bristol, TN-VA market, with the plurality of this provider's patient population coming from Sullivan, TN. This provider's primary affiliated billing organization is CALLADERM LLC (NPI: 1316283252; TIN: 46-1720844) and primary practice location at 37660-7484.

Reaves' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 942 traditional Medicare patients, billed 7,258 HCPCS/CPT codes, and received $268,418 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 396 prescription claims across 247 beneficiaries totaling $116,815 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 3 records totaling $71. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $202,517 and ending at $268,418. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $270,797 to $116,815. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	434	3,441	$202,517
2016	532	3,758	$217,423
2017	648	4,776	$251,796
2018	950	5,496	$447,160
2019	716	5,187	$306,213
2020	510	3,192	$170,738
2021	703	5,070	$252,641
2022	757	5,618	$229,104
2023	790	5,722	$249,672
2024	942	7,258	$268,418

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	342	753	$270,797
2016	366	770	$358,684
2017	433	961	$403,178
2018	320	603	$350,169
2019	236	415	$162,943
2020	212	394	$113,001
2021	197	338	$57,541
2022	218	387	$133,354
2023	170	301	$143,498
2024	247	396	$116,815

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	204	315	$71
11102	Biopsy of related skin growth, first growth	397	487	$55
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	755	1,443	$52
17000	Destruction of precancer skin growth, 1 growth	514	743	$32
17003	Destruction of precancer skin growth, 2-14 growths	411	2,422	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Fluorouracil	Fluorouracil	59	1,840	$5,126
Betamethasone Dipropionate	Betamethasone Dipropionate	30	678	$842
Doxycycline Hyclate	Doxycycline Hyclate	21	623	$698
Ketoconazole	Ketoconazole	32	951	$664
Clobetasol Propionate	Clobetasol Propionate	11	279	$506

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$71	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jami Lynn Reaves, DO?

Tedicare shows public-source Medicare data for Jami Lynn Reaves, DO (NPI 1679783567), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jami Lynn Reaves, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jami Lynn Reaves, DO?

Jami Lynn Reaves, DO is linked to CALLADERM LLC (billing NPI 1316283252) in the available physician profile data.

Does Jami Lynn Reaves, DO have Open Payments data?

Jami Lynn Reaves, DO has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.